The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States-Reference-Cited by-同舟云学术

The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States

Published:2021-11-18 Issue: Volume: Page:
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Dore Robin K.¹,Antonova Jenya N.²^ORCID,Burudpakdee Chakkarin³,Chang Lawrence²,Gorritz Magdaliz³,Genovese Mark C.²⁴

Affiliation:

1. Private practice Tustin California

2. Gilead Sciences Foster City California

3. IQVIA, Plymouth Meeting Pennsylvania

4. Division of Immunology and Rheumatology Stanford University Stanford California

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11376

Reference44 articles.

1. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2. Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis

3. Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis

4. Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster

5. The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association;Circulation;2024-02-20

2. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry;Rheumatology International;2023-12-29

3. Venous Thromboembolism in Rheumatoid Arthritis: The Added Effect of Disease Activity to Traditional Risk Factors;Open Access Rheumatology: Research and Reviews;2022-10

4. A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19;Advances in Therapy;2022-09-05